© Copyright Nostre Net
Market Analysis
The
Global Narcolepsy
Market trendsis likely to grow
at an 8.2% CAGR between 2017- 2023, according to the recent Market Research
Future (MRFR) report. Narcolepsy is a rare condition that is oftentimes
under-diagnosed. It is characterized by automatic behaviors, cataplexy,
excessive day time sleepiness, sleep paralysis, hallucination, and excessive
sleepiness. This disorder is caused by the lack of orexin, a brain chemical
that regulates sleep. Puberty and menopause are other factors that can trigger
narcolepsy.
Get Sample
Report @https://www.marketresearchfuture.com/sample_request/5701
On
the contrary, low per capita healthcare expenditure in middle & low-income
countries and lack of awareness are factors that may impede the global
narcolepsy market growth over the forecast period.
Key Players
Notable
players profiled in the global narcolepsy market report include Ligand
Pharmaceuticals, Inc. (U.S.), Shionogi Inc. (U.S.), Shire (Republic of
Ireland), Novartis AG (Switzerland), Teva Pharmaceutical Industries Ltd.
(Israel), Mylan N.V. (US), Graymark Healthcare, Inc. (US), Arena
Pharmaceuticals, Inc. (US), BIOPROJET (Paris), and Jazz Pharmaceuticals Plc
(Republic of Ireland).
Market Segmentation
The
MRFR report provides an inclusive segmental analysis of the global narcolepsy
market based on end user, treatment, type, and diagnosis.
By
type, the global narcolepsy market is segmented into type 2 narcolepsy, type 1
narcolepsy, and others.
By
diagnosis, the global narcolepsy market is segmented into multiple sleep
latency test, polysomnogram, and others.
By
treatment, the global narcolepsy market is segmented into sodium oxybate,
antidepressants, stimulants, and others. The stimulants segment is again segmented
into armodafinil, modafinil, and others. The antidepressants segment is again
segmented into noradrenergic reuptake inhibitors, selective serotonin,
tricyclics, and others. The tricyclics segment is again segmented into
clomipramine, desipramine, imipramine, and others. The selective serotonin
& noradrenergic segment is again segmented into fluoxetine, venlafaxine,
and others.
By
end users, the global narcolepsy market is segmented into retail pharmacies,
clinics, hospitals, and others.
Regional Analysis
Based
on the region, the global narcolepsy market covers the recent trends and growth
opportunities across Europe, the Americas, the Asia Pacific (APAC), and the
Middle East and Africa (MEA). Of these, the Americas will have the lions share
in the market over the forecast period for a huge patient population, high
healthcare expenditure, the presence of key industry players, and a
well-developed healthcare sector. Canada and the US are the chief contributors
in the region.
The
global narcolepsy market in Europe is predicted to have the second-largest
share over the forecast period for the presence of developed economies such as
Germany, Italy, and France, increasing cases of obesity, huge patient
population, and availability of funds for research and development.
The
global narcolepsy market in the APAC region is predicted to grow at a quick
pace over the forecast period for favorable government policies, developing
healthcare sector, and the presence of developing economies such as China &
India.
The
global narcolepsy market in the MEA is predicted to have the smallest share in
the market over the forecast period for stringent government policies in the
African region and weak economies. The market in the Middle East will have a
favorable growth for the huge healthcare expenditure due to the presence of
several developed economies such as Qatar, Kuwait, and Saudi Arabia.
Get Complete
Report Details @ https://www.marketresearchfuture.com/reports/narcolepsy-market-5701
Browse More
Related Reports:
Endovascular
Aneurysm Repair Devices Market @ https://www.marketresearchfuture.com/reports/endovascular-aneurysm-repair-devices-market-6485
Healthcare
Cloud Computing Market @https://www.marketresearchfuture.com/reports/healthcare-cloud-computing-market-6519
High Potency
APIs Market @https://www.marketresearchfuture.com/reports/high-potency-apis-market-6679
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York 10013,
United States of
America
The Wall